Intravascular lithotripsy

Intravascular lithotripsy (IVL) helps interventional cardiologists break down heavily calcified plaques in the coronary and peripheral arteries prior to percutaneous coronary intervention. Shockwave Medical, now a part of Johnson & Johnson MedTech, got the ball rolling with its IVL therapies that use shockwave pulses to clear out the calcified plaques. Several other companies have now entered the space, working to develop their own IVL systems that can improve patient outcomes.

Medical device company raises $36M for emitter-free IVL platform
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.
Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology
Intravascular lithotripsy has quickly emerged as one of healthcare’s most in-demand technologies. Now Shockwave Medical, part of Johnson & Johnson MedTech, is co-hosting a webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures.
Boston Scientific enters IVL arms race with acquisition worth up to $664M
Boston Scientific has agreed to acquire Bolt Medical, a California-based medical device company focused on developing new intravascular lithotripsy technologies. The news comes less than one year after Johnson & Johnson acquired IVL pioneers Shockwave Medical for $13 billion.
Intravascular lithotripsy technology now a top priority for many healthcare companies
After the significant success of Shockwave Medical's IVL therapy to break up heavily calcified vessels without trauma, there are now several companies working on their own IVL devices.
Shockwave Medical’s IVL technology still safe, effective in patients with calcified nodules
Intravascular lithotripsy is still a safe and effective frontline preparation tool when PCI patients present with calcified nodules, a new two-year study confirmed. Researchers focused on stent expansion and luminal gain, among other key data points.

Shockwave Medical C2+ catheter TCT 2023 announcement

Shockwave Medical introducing more efficient IVL catheter to US market at TCT 2023

According to Shockwave, the updated IVL catheter can deliver 50% more pulses than its previous offering.

Shockwave L6 Peripheral IVL Catheter Shockwave Medical

Shockwave Medical launches new IVL catheter for challenging lesions in US

After its initial release was limited to certain customers, the new-look catheter is now available in four different sizes throughout the United States.

Coronary IVL now recommended at all cath labs, even those without surgical backup

The latest SCAI guidance on the safety of PCI procedures included a key change that could expand coronary IVL utilization throughout the United States.

IVL for calcified lesions: Where the technology stands now and where it's headed

In a new analysis, researchers highlighted IVL’s potential for helping with the treatment of coronary artery disease.

‘An important validation’: CMS issues new codes for IVL procedures

CMS has issued new codes for intravascular lithotripsy (IVL) procedures performed in a patient’s peripheral arteries in both the hospital outpatient and inpatient settings.

Intravascular lithotripsy

Medical device company raises $36M for emitter-free IVL platform

Experts in interventional cardiology, medical billing unite to discuss Shockwave Medical’s IVL technology

Boston Scientific enters IVL arms race with acquisition worth up to $664M

Intravascular lithotripsy technology now a top priority for many healthcare companies

Shockwave Medical’s IVL technology still safe, effective in patients with calcified nodules